• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于 COVID-19 新兴治疗干预措施的观点。

A Perspective on Emerging Therapeutic Interventions for COVID-19.

机构信息

Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.

Department of Chemistry, Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.

出版信息

Front Public Health. 2020 Jul 3;8:281. doi: 10.3389/fpubh.2020.00281. eCollection 2020.

DOI:10.3389/fpubh.2020.00281
PMID:32733837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7362761/
Abstract

Coronaviruses are enveloped positive-sense RNA viruses with an unusual large RNA genome and a unique replication mechanism, which are characterized by club-like spikes that protrude from their surface. An outbreak of a novel coronavirus 2019 infection has posed significant threat to the health and economies in the whole world. This article reviewed the viral replication, pathogenicity, prevention and treatment strategies. With a lack of approved treatment options for this virus, alternative approaches to control the spread of disease is in urgent need. This article also covers some management strategies which may be applied to this virus outbreak. Ongoing clinical studies related to possible treatments for COVID-19, potential vaccines, and alternative medication such as natural compounds are also discussed.

摘要

冠状病毒是带有不寻常大 RNA 基因组和独特复制机制的包膜正链 RNA 病毒,其表面有棒状突起的刺突。2019 年新型冠状病毒的爆发对全球健康和经济构成了重大威胁。本文综述了病毒的复制、致病性、预防和治疗策略。由于缺乏针对该病毒的批准治疗方法,因此迫切需要控制疾病传播的替代方法。本文还涵盖了一些可能适用于该病毒爆发的管理策略。此外,还讨论了与 COVID-19 可能治疗方法、潜在疫苗以及天然化合物等替代药物相关的正在进行的临床研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/c850950e65f4/fpubh-08-00281-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/3c328771011a/fpubh-08-00281-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/259466070fa8/fpubh-08-00281-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/a764b2717cb1/fpubh-08-00281-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/c850950e65f4/fpubh-08-00281-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/3c328771011a/fpubh-08-00281-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/259466070fa8/fpubh-08-00281-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/a764b2717cb1/fpubh-08-00281-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe4/7362761/c850950e65f4/fpubh-08-00281-g0004.jpg

相似文献

1
A Perspective on Emerging Therapeutic Interventions for COVID-19.关于 COVID-19 新兴治疗干预措施的观点。
Front Public Health. 2020 Jul 3;8:281. doi: 10.3389/fpubh.2020.00281. eCollection 2020.
2
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.新型冠状病毒治疗药物的安全性、临床应用和抗病毒研究概述。
J Infect Public Health. 2020 Oct;13(10):1405-1414. doi: 10.1016/j.jiph.2020.07.004. Epub 2020 Jul 13.
3
Repurposing antimalarials and other drugs for COVID-19.将抗疟药及其他药物重新用于治疗新冠肺炎。
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
4
Current treatment strategies for COVID‑19 (Review).2019冠状病毒病的当前治疗策略(综述)
Mol Med Rep. 2021 Dec;24(6). doi: 10.3892/mmr.2021.12498. Epub 2021 Oct 19.
5
What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside.从 COVID-19 大流行中我们所学到的:是时候跳出固有思维了,也许要远远地跳出去。
Clin Dermatol. 2021 Jan-Feb;39(1):107-117. doi: 10.1016/j.clindermatol.2020.12.020. Epub 2020 Dec 16.
6
Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.羟氯喹和瑞德西韦治疗 COVID-19:对近期事件的批判性分析。
Indian J Med Ethics. 2020 Jul-Sep;V(3):202-207. doi: 10.20529/IJME.2020.068.
7
Current pharmacological treatments for SARS-COV-2: A narrative review.新型冠状病毒肺炎的当前药物治疗:一篇叙述性综述。
Eur J Pharmacol. 2020 Sep 5;882:173328. doi: 10.1016/j.ejphar.2020.173328. Epub 2020 Jun 27.
8
Possible treatment and strategies for COVID-19: review and assessment.针对 COVID-19 的可能治疗方法和策略:综述与评估。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12593-12608. doi: 10.26355/eurrev_202012_24057.
9
A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.瑞德西韦、羟氯喹和洛匹那韦-利托那韦治疗 COVID-19 的临床前和临床疗效评价综述。
SLAS Discov. 2020 Dec;25(10):1108-1122. doi: 10.1177/2472555220958385. Epub 2020 Sep 17.
10
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic.SARS-CoV-2 和 COVID-19 的病毒特性、传播、病理生理学、免疫反应和管理的全面综述,为控制大流行提供了依据。
Front Immunol. 2021 Feb 26;12:631139. doi: 10.3389/fimmu.2021.631139. eCollection 2021.

引用本文的文献

1
Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community's view.为潜在的高传染性呼吸道疾病建立国际候选疫苗库的时机:社区观点
EClinicalMedicine. 2023 Sep 26;64:102222. doi: 10.1016/j.eclinm.2023.102222. eCollection 2023 Oct.
2
FOXA2 attenuates lipopolysaccharide‑induced pneumonia by inhibiting the inflammatory response, oxidative stress and apoptosis through blocking of p38/STAT3 signaling.叉头框蛋白A2(FOXA2)通过阻断p38/信号转导和转录激活因子3(STAT3)信号通路,抑制炎症反应、氧化应激和细胞凋亡,从而减轻脂多糖诱导的肺炎。
Exp Ther Med. 2023 Aug 17;26(4):469. doi: 10.3892/etm.2023.12168. eCollection 2023 Oct.
3

本文引用的文献

1
Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates.新型冠状病毒 2019-nCoV (COVID-19):流行病学参数和疫情规模的早期估计。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200265. doi: 10.1098/rstb.2020.0265. Epub 2021 May 31.
2
Textile Masks and Surface Covers-A Spray Simulation Method and a "Universal Droplet Reduction Model" Against Respiratory Pandemics.纺织口罩和表面覆盖物——一种针对呼吸道大流行的喷雾模拟方法及“通用飞沫减少模型”
Front Med (Lausanne). 2020 May 27;7:260. doi: 10.3389/fmed.2020.00260. eCollection 2020.
3
COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence.
Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination.
COVID-19 和流感疫苗接种对风湿性疾病的影响:基于疫苗接种后患者报告结局的调查结果。
J Korean Med Sci. 2023 Aug 14;38(32):e247. doi: 10.3346/jkms.2023.38.e247.
4
COVID-19 Vaccine Impacts in Saudi Arabia: A Cross-Sectional Study.新冠病毒疫苗在沙特阿拉伯的影响:一项横断面研究。
Cureus. 2023 Jun 15;15(6):e40460. doi: 10.7759/cureus.40460. eCollection 2023 Jun.
5
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs.COVID-19 腺病毒载体疫苗在人 PBMCs、巨噬细胞和 moDCs 中诱导的干扰素和促炎反应高于 mRNA 疫苗。
Vaccine. 2023 Jun 13;41(26):3813-3823. doi: 10.1016/j.vaccine.2023.04.049. Epub 2023 Apr 25.
6
Lactate dehydrogenase and aspartate aminotransferase levels associated with the severity of COVID‑19: A systematic review and meta‑analysis.乳酸脱氢酶和天冬氨酸转氨酶水平与新型冠状病毒肺炎严重程度的相关性:一项系统评价和荟萃分析。
Exp Ther Med. 2023 Mar 29;25(5):221. doi: 10.3892/etm.2023.11920. eCollection 2023 May.
7
Dynamic changes in radiological parameters, immune cells, selected miRNAs, and cytokine levels in peripheral blood of patients with severe COVID‑19.重症新型冠状病毒肺炎患者外周血中放射学参数、免疫细胞、特定微小RNA及细胞因子水平的动态变化
Biomed Rep. 2023 Mar 21;18(5):33. doi: 10.3892/br.2023.1615. eCollection 2023 May.
8
Natural essential oils as a new therapeutic tool in colorectal cancer.天然精油作为结直肠癌的一种新型治疗工具。
Cancer Cell Int. 2022 Dec 13;22(1):407. doi: 10.1186/s12935-022-02806-5.
9
Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation.植物化学物质在阿尔茨海默病中的多靶点作用机制:对氧化应激、神经炎症和蛋白质聚集的影响
J Pers Med. 2022 Sep 15;12(9):1515. doi: 10.3390/jpm12091515.
10
Molecular Communications in Viral Infections Research: Modeling, Experimental Data, and Future Directions.病毒感染研究中的分子通讯:建模、实验数据及未来方向
IEEE Trans Mol Biol Multiscale Commun. 2021 Apr 15;7(3):121-141. doi: 10.1109/TMBMC.2021.3071780. eCollection 2021 Sep.
COVID-19,重新评估人为污染物对病毒流行/大流行事件和流行率的长期影响之间相关性的机会。
Food Chem Toxicol. 2020 Jul;141:111418. doi: 10.1016/j.fct.2020.111418. Epub 2020 May 11.
4
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].羟氯喹治疗中度新型冠状病毒肺炎患者的一项试点研究
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03.
5
Convalescent plasma in Covid-19: Possible mechanisms of action.恢复期血浆治疗 COVID-19:可能的作用机制。
Autoimmun Rev. 2020 Jul;19(7):102554. doi: 10.1016/j.autrev.2020.102554. Epub 2020 May 5.
6
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).迈向有效的 COVID-19 疫苗:更新、观点和挑战(综述)。
Int J Mol Med. 2020 Jul;46(1):3-16. doi: 10.3892/ijmm.2020.4596. Epub 2020 May 6.
7
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system.社论:尼古丁与严重急性呼吸综合征冠状病毒2:2019冠状病毒病可能是一种烟碱能胆碱能系统疾病。
Toxicol Rep. 2020 Apr 30;7:658-663. doi: 10.1016/j.toxrep.2020.04.012. eCollection 2020.
8
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
9
Camostat mesilate therapy for COVID-19.甲磺酸卡莫司他治疗新型冠状病毒肺炎
Intern Emerg Med. 2020 Nov;15(8):1577-1578. doi: 10.1007/s11739-020-02345-9. Epub 2020 Apr 29.
10
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.乌米酚韦治疗与改善 2019 冠状病毒病患者结局无关:一项回顾性研究。
Clin Microbiol Infect. 2020 Jul;26(7):917-921. doi: 10.1016/j.cmi.2020.04.026. Epub 2020 Apr 25.